Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix

doi:10.12998/wjcc.v8.i17.3697

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5585)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

335

WORD

210

HTML

2687

Figures (1-4)

277

Tables (1-3)

289

Sum=3798

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

536

Download

1251

Sum=1787

Sep 6, 2020 (publication date) through Dec 3, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 6, 2020; 8(17): 3697-3707
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3697

Full Size Figure Download Figure

Figure 4 Median progression- free survival in somatostatin receptor scintigraphy. Median progression- free survival in somatostatin receptor scintigraphy positive patients was 52 months (95% confidence interval: 39.7-117.3) while in somatostatin receptor scintigraphy negative patients it was 60 months (95% confidence interval: 42.8-77.1), without statistically significant difference between the two groups (P = 0.434).

Citation: Saponjski J, Macut D, Sobic-Saranovic D, Ognjanovic S, Bozic Antic I, Pavlovic D, Artiko V. Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix. World J Clin Cases 2020; 8(17): 3697-3707
URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3697.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3697